Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Mayıs 2012 tarihinde katıldı
5 Fotoğraf ve video Fotoğraflar ve videolar

Tweetler

@AblynxABLX adlı kişiyi engelledin

Bu Tweetleri görüntülemek istediğinden emin misin? Tweetleri görüntülemek @AblynxABLX adlı kişinin engelini kaldırmaz.

  1. Retweetledi
    26 Tem

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 retweet 4 beğenme
  2. Retweetledi
    20 Tem

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 retweet 7 beğenme
  3. 20 Tem

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    9 retweet 14 beğenme
  4. 27 Haz

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 retweet 16 beğenme
  5. 26 Haz

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 retweet 6 beğenme
  6. 29 May

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 retweet 9 beğenme
  7. 22 May

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 retweet 12 beğenme
  8. 18 May

    Meet our experts and recruiters (booth 99) @

    2 beğenme
  9. 11 May

    Ablynx zit op schema via

    4 retweet 6 beğenme
  10. 11 May

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 retweet 4 beğenme
  11. 10 May

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 retweet 7 beğenme
  12. 2 May

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 retweet 6 beğenme
  13. 7 Nis

    Annual Report 2016 is available online - view via

    4 beğenme
  14. 7 Nis

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    4 beğenme
  15. Retweetledi
    6 Mar

    Compelling data for developed psoriasis nanobody in collaboration

    3 retweet 2 beğenme
  16. Retweetledi
    28 Şub

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 yanıt 51 retweet 103 beğenme
  17. Retweetledi
    24 Şub

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 beğenme
  18. 23 Şub

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 retweet 3 beğenme
  19. 9 Şub

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 retweet 2 beğenme
  20. 6 Şub

    Ablynx files caplacizumab for ultra rare blood disorder
    6 retweet 9 beğenme

@AblynxABLX henüz hiç Tweetlemedi.

Yükleme biraz zaman alacak gibi görünüyor.

Twitter aşırı kapasiteyle çalışıyor ya da anlık sorunlar yaşıyor olabilir. Yeniden dene ya da daha fazla bilgi almak için Twitter Durumu sayfasını ziyaret et.

    Şunları da beğenebilirsin

    ·